Jaguar Health, Inc

JAGXNASDAQ · Pharmaceutical Preparations

Financing

SEC filings to 2026-10-05 · every row opens its filing

No share count on file in the XBRL facts for this window.

Newest

S-3 of 2025-10-03. Not read yet. S-3 ↗

$9.8M

Agreement of 2026-09-24. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗

Warrants

148K

Warrants of every class as tagged in the XBRL facts on 2026-06-30. 10-Q ↗

Cash

2.3 quarters

$3.8M on 2026-06-30 ÷ $1.7M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
Date	What	Shares	Price	Gross	Filing
2026-06-09	Private placement	240	not read	$2.0M	8-K ↗

Also on file: a 1-for-15 reverse split, 2026-04-20 8-K ↗